Lv4
420 积分 2021-10-14 加入
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
1个月前
已完结
Software with artificial intelligence-derived algorithms for detecting and analysing lung nodules in CT scans: systematic review and economic evaluation
2个月前
已关闭
Leveraging Artificial Intelligence to Transform Thoracic Radiology for Lung Nodules and Lung Cancer
2个月前
已关闭
Artificial Intelligence–Driven Three‐Dimensional Reconstruction in Lung Cancer Surgery: Current Status and Future Perspectives
2个月前
已完结
Artificial intelligence in lung cancer: from diagnosis to therapy
2个月前
已完结
Time-of-day immunochemotherapy in nonsmall cell lung cancer: a randomized phase 3 trial
3个月前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
4个月前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
6个月前
已完结
Survival with Osimertinib plus Chemotherapy in EGFR -Mutated Advanced NSCLC
7个月前
已完结
Sevabertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
7个月前
已完结
皖公网安备34019202002308
